Arthritis Research Canada’s scientific experts have been at the forefront of cardiovascular disease research since the launch of PRECISION (Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions) – a $2.5 million project funded by the Canadian Institutes for Health Research and the Crohn’s and Colitis Foundation of Canada.
Our scientists are studying the risk of cardiovascular disease in people with different types of arthritis, including rheumatoid arthritis, gout, ankylosing spondylitis, Sjögren Syndrome, systemic lupus erythematosus, granulomatosis with polyangiitis, systemic sclerosis, polymyositis, dermatomyositis, giant cell arteritis, and more.
The goal is to understand the risk of cardiovascular events like heart attacks, strokes and blood clots in the legs and lungs and to also identify ways to prevent or decrease these serious, life-threatening complications.
Research Scientist
Dr. Antonio Aviña-Zubieta, MD, MSc, PhD, FRCP
Senior Scientist of Rheumatology, Arthritis Research Canada
Dr. Antonio Aviña-Zubieta is an Associate Professor in the Division of Rheumatology, Department of Medicine, at the University of British Columbia (UBC). He is also a senior scientist at Arthritis Research Canada, a practicing rheumatologist, the BC Lupus Society Research Scholar and the Walter & Marilyn Booth Research Scholar.
Research Study Summaries:
PRECISION: Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions
Research Publications:
- Ten-year risk of cerebrovascular accidents in incident rheumatoid arthritis: A population-based study of trends over time
- The risk and trend of pulmonary embolism and deep Vein thrombosis in rheumatoid arthritis: A general population-based study
- Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: A general-population-based cohort study
- Trends of venous thromboembolism risk before and after diagnosis of gout: A general population-based study
- The risk of venous thromboembolism in ankylosing spondylitis: A general population-based study
- All-cause and cause-specific mortality in granulomatosis with polyangiitis: A population-based Study
- Quality of care for cardiovascular disease prevention in RA: Compliance with diabetes screening guidelines
- Quality of care for cardiovascular disease prevention in rheumatoid arthritis: Compliance with hyperlipidemia screening guidelines
- Temporal trends of venous thromboembolism risk before and after diagnosis of giant cell arteritis
- The risk of deep venous thrombosis and pulmonary embolism in primary Sjögren Syndrome: A general population-based study
- Quality of care for cardiovascular disease prevention in RA: Compliance with diabetes screening guidelines
- The risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: A general population-based study
- Risk of myocardial infarction and stroke in patients with granulomatosis with polyangiitis (Wegener’s): A population-based study
- Early cardiovascular disease after the diagnosis of systemic sclerosis
- Validity of diagnostic codes for acute stroke in administrative databases: A systematic review
- The risk of pulmonary embolism and deep venous thrombosis in systemic sclerosis: A general population-based study
- Risk of myocardial infarction and ischaemic stroke in individuals with polymyositis and dermatomyositis: A general population-based study
- The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study
- Increased risk of cardiovascular disease in giant cell arteritis: A general population-based study
- Development of cardiovascular quality indicators for rheumatoid arthritis: Results from an international expert panel using a novel online process
- The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: A population-based study
- Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: A general population-based study
- Validity of heart failure diagnoses in administrative databases: A systematic review and meta-analysis
- Best practices for cardiovascular disease prevention in rheumatoid arthritis: A systematic review of guideline recommendations and quality indicators
- Validity of myocardial infarction diagnoses in administrative databases: A systematic review
- Overall and cause-specific mortality in patients with systemic lupus erythematosus: A meta-analysis of observational studies
- The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: A UK population-based outpatient cohort study
- Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: A population-based study
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: A meta-analysis of observational studies
- Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: A population-based study
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
